Transmeta The Rise and Fall of a Pioneering Chip Maker

Transmeta was a pioneering chip maker that made waves in the tech industry with its innovative approach to processor design. Founded in 1995 by David Ditzel and Bill Pearce, the company aimed to create a more efficient and power-friendly processor.

The company's breakthrough came with the introduction of the Crusoe processor in 2000, which used a revolutionary approach called VLIW (Very Long Instruction Word) to process multiple instructions at once. This allowed for a significant reduction in power consumption and heat generation.

Transmeta's processors were initially met with skepticism by industry insiders, but they quickly gained traction with laptop manufacturers who were looking for ways to extend battery life. The company's processors were used in several high-profile laptops, including the IBM ThinkPad.

Despite its innovative approach, Transmeta struggled to compete with established chip makers like Intel and AMD, and the company's fortunes began to decline in the mid-2000s.

Consider reading: Niagara Mohawk Power Corporation

Transmeta was founded in 1995 by a group of seven individuals, including Bob Cmelik, Dave Ditzel, Colin Hunter, Ed Kelly, Doug Laird, Malcolm Wing, and Greg Zyner.

These founders had a clear vision for the company, but they kept it under wraps, leading to a lot of speculation and buzz in the tech industry.

Transmeta was known as a stealth startup, and it wasn't until 1998 that some of the details about their plans started to leak out.

JC Dovrak wrote in a December 1998 column of PC Mag that Transmeta was working on an ultra-low power x86 clone, designed for modern notebooks.

The company remained tight-lipped about its plans, but eventually, a comment in the HTML of their website revealed that they would announce and demonstrate their Crusoe processors on January 19, 2000.

On May 31, 2005, Transmeta announced the signing of asset purchase and license agreements with Hong Kong’s Culture.com Technology Limited, but the deal ultimately fell apart due to delays in obtaining technology export licenses.

Intellectual Venture Funding LLC acquired Transmeta's patent portfolio in 2009, bringing an end to the company's involvement in the tech industry.

Transmeta made its public debut on March 21, 2000, with a stock offering that raised $140 million.

The company's stock was initially priced at $14 per share, but it quickly rose to $35 within the first day of trading.

The public launch was met with a mix of excitement and skepticism, with some analysts questioning the viability of Transmeta's x86 processor technology.

Transmeta's initial public offering (IPO) was oversubscribed, with more investors interested in the company than there were shares available.

The company's stock price continued to rise throughout the year, reaching a high of $67 per share in July 2000.

Transmeta's public launch marked a significant milestone for the company, but it also brought increased scrutiny and competition from established technology players.

Related reading: Central Illinois Public Service Company

Transmeta was fortunate to have some of the industry's most public figures on its team, including Linux founder Linus Torvalds.

Linus Torvalds, the creator of Linux, was one of the notable employees of Transmeta. Linux kernel developer Hans Peter Anvin was also part of the crew.

The presence of these influential figures led to excellent press relations, as the industry was constantly abuzz with rumors and "conspiracy theories".

Transmeta received a total of $969M in funding during its lifetime. This significant investment was crucial for the company's growth and development.

In 1996, Transmeta secured $288 million in initial funding, which laid the foundation for its future endeavors. The company continued to receive funding throughout its lifetime, with a notable $88 million raised in Q2 2000.

Transmeta's funding history also includes a significant $273 million raised through an IPO in Q4 2000. This influx of capital helped the company expand its operations and pursue new opportunities.

Broaden your view: Trek 2000 International

Transmeta received a total of $969M in funding during its lifetime. This is a significant amount of money, and it's interesting to break down where it came from.

In 1996, Transmeta received $288 million in funding. This was a crucial investment that helped the company get off the ground.

Transmeta also received funding through initial public offerings (IPOs) and secondary offerings. In 2000, the company raised $88 million in the second quarter and $273 million in the fourth quarter. This influx of capital helped Transmeta expand its operations and pursue new opportunities.

In 2003, Transmeta received $83 million in funding through a secondary offering. This was a key moment in the company's history, as it helped Transmeta continue to grow and develop its products.

Transmeta also received funding from major technology companies. In 2007, the company received $7.5 million from AMD and $150 million from Intel as part of a settlement. The following year, Transmeta received $80 million from Intel as part of another settlement.

Here is a breakdown of Transmeta's funding by year:

Transmeta, a fabless semiconductor company, relied on other companies to fabricate their processor designs. This means they didn't have their own facilities to make the chips.

Their processors, including the Crusoe, were fabricated by IBM Microelectronics, the semiconductor business of IBM. IBM used a 0.18 μm CMOS process to make the Crusoe, which is a specific type of manufacturing process.

IBM also used five levels of copper interconnect in the Crusoe's fabrication process.

See what others are reading: Magnum Semiconductor

The Efficeon microprocessor was a significant improvement over Transmeta's previous processor, Crusoe. It was a 256-bit VLIW processor design that prioritized computational efficiency, low power consumption, and a small thermal footprint.

The 2004-model 1.6-GHz Transmeta Efficeon had roughly the same performance and power characteristics as a 1.6-GHz Intel Atom from 2008. This was impressive, considering the Atom was manufactured using a more advanced 45 nm process.

Efficeon's integrated Northbridge reduced power consumption compared to the competing Atom, which required an external Northbridge chip. This was a key advantage for Efficeon.

The Efficeon processor showed a roughly 2x real-world improvement over Crusoe, addressing many of its shortcomings. This made it a more viable option for users.

Efficeon's die was significantly smaller than Pentium 4 and Pentium M processors, despite having a 1 MB L2 cache. Its 90 nm die measured 68 mm, which was 60% of the Pentium 4's 90 nm die size of 112 mm.

Intriguing read: Idaho Power

Transmeta processors used a special dynamic binary translation software layer called Code Morphing Software (CMS) to implement compatibility with the x86 architecture.

This software layer was trademarked by Transmeta as "Code Morphing" and was a key part of their technology.

Transmeta also used reverse body bias to reduce power consumption by a factor of about 2.5, a technology also used in XScale processors.

The power consumption of Efficeon processors was moderate, with some consuming as little as 3 watts at 1 GHz and 7 watts at 1.5 GHz, making them suitable for passive cooling.

Efficeon had a 128-KB L1 instruction cache, a 64-KB L1 data cache, and a 1-MB L2 cache, all of which were on-die.

The Crusoe processor has some limitations when it comes to software compatibility. It only supports MMX, not SSE, which is a significant issue.

Most browsers on Windows and Linux, as well as some other programs, need SSE or SSE2 support to run, making them incompatible with the Crusoe platform.

Firefox dropped support for systems without SSE2 in 2017, which means users can't run the latest versions of the browser on Crusoe.

Transmeta has filed 8 patents, with the first one being for "Adaptive control of operating and body bias voltages", which was granted on July 14, 2009.

The patent was filed on June 22, 2004, and is related to control theorists, analog circuits, electrical engineering, electronic circuits, and capacitors.

Transmeta's patents cover processor design and power-efficiency techniques, and Intel has agreed to license these patents for use in future products.

Intel will pay Transmeta $150 million initially and $20 million in each of the next five years, totaling $250 million, to settle a dispute over patent infringement.

Here's a list of some of the topics related to Transmeta's patents:

The design of Transmeta's processors is quite fascinating. They used a very long instruction word (VLIW) core, which allowed for a 256-bit VLIW instruction to be executed per cycle.

Transmeta's VLIW core is made up of several units, including two arithmetic logic units, two load/store/add units, two execute units, two floating-point/MMX/SSE/SSE2 units, one branch prediction unit, one alias unit, and one control unit.

The Efficeon processor, in particular, had a 128-KB L1 instruction cache, a 64-KB L1 data cache, and a 1-MB L2 cache, all of which were on die.

Transmeta's processors also used a technique called reverse body bias to reduce power consumption by a factor of about 2.5.

The Efficeon processor came in two package types: a 783- and a 592-contact ball grid array, and its power consumption was moderate, with some consuming as little as 3 watts at 1 GHz and 7 watts at 1.5 GHz.

Here's a breakdown of the Efficeon's architecture:

Transmeta's Code Morphing Software (CMS) reserved a small portion of main memory (typically 32 MB) for its cache of dynamically translated x86 instructions.